ZYPELZY

Serial Number 79405975
Registration 7789786
700

Registration Progress

Application Filed
Aug 27, 2024
Under Examination
Approved for Publication
Mar 19, 2025
Published for Opposition
Mar 25, 2025
Registered
May 13, 2025

Trademark Image

ZYPELZY

Basic Information

Serial Number
79405975
Registration Number
7789786
Filing Date
August 27, 2024
Registration Date
May 13, 2025
Published for Opposition
March 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 13, 2025
Registration
Registered
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Owner at Publication
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Original Registrant
03
JP

USPTO Deadlines

Next Deadline
1948 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250513)
Due Date
May 13, 2031
Grace Period Ends
November 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Jun 12, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 13, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 19, 2025 NPUB O NOTICE OF PUBLICATION Loading...
Mar 4, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 3, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 9, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 9, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 9, 2024 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Oct 3, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Classification

International Classes
005